![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 18
Zeitschriftenartikel
Paulmann, Carmen; Spallek, Ria; Karpiuk, Oleksandra; Heider, Michael; Schäffer, Isabell; Zecha, Jana; Klaeger, Susan; Walzik, Michaela; Öllinger, Rupert; Engleitner, Thomas; Wirth, Matthias; Keller, Ulrich; Krönke, Jan; Rudelius, Martina; Kossatz, Susanne; Rad, Roland; Kuster, Bernhard und Bassermann, Florian
(2022):
The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma.
In: EMBO Journal, Bd. 41, Nr. 20, e110871
Demel, Uta M.; Boeger, Marlitt; Yousefian, Schayan; Grunert, Corinna; Zhang, Le; Hotz, Paul W.; Gottschlich, Adrian; Koese, Hazal; Isaakidis, Konstandina; Vonficht, Dominik; Gruenschlaeger, Florian; Rohleder, Elena; Wagner, Kristina; Doenig, Judith; Igl, Veronika; Brzezicha, Bernadette; Baumgartner, Francis; Habringer, Stefan; Loeber, Jens; Chapuy, Bjoern; Weidinger, Carl; Kobold, Sebastian; Haas, Simon; Busse, Antonia B.; Mueller, Stefan; Wirth, Matthias; Schick, Markus und Keller, Ulrich
(2022):
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer.
In: Journal of Clinical Investigation, Bd. 132, Nr. 9, e152383
Stroh, Jacob; Seckinger, Anja; Heider, Michael; Rudelius, Martina; Eichner, Ruth; Schick, Markus; Slawska, Jolanta; Emde-Rajaratnam, Martina; Salwender, Hans; Bertsch, Uta; Goldschmidt, Hartmut; Weisel, Katja; Scheid, Christof; Keller, Ulrich; Hose, Dirk und Bassermann, Florian
(2022):
MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma.
In: Blood Advances, Bd. 6, Nr. 2: S. 515-520
Hess, Georg; Huettmann, Andreas; Witzens-Harig, Mathias; Dreyling, Martin H.; Keller, Ulrich; Marks, Reinhard; Ernst, Thomas; Pott, Christiane; Viardot, Andreas; Frontzek, Fabian; Trautmann, Marcel; Ruckes, Christian; Deuster, Oliver; Rosenwald, Andreas; Theobald, Matthias und Lenz, Georg
(2022):
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
In: British Journal of Haematology, Bd. 198, Nr. 3: S. 482-491
Borchmann, Peter; Plutschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S.; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sokler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V.; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Huttmann, Andreas; Wilhelm, Martin; Zijlstra, Josee M.; Moccia, Alden; Kuhnert, Georg; Brockelmann, Paul J.; Tresckow, Bastian von; Fuchs, Michael; Klimm, Beate; Rosenwald, Andreas; Eich, Hans; Baues, Christian; Marnitz, Simone; Hallek, Michael; Diehl, Volker; Dietlein, Markus und Engert, Andreas
(2021):
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial.
In: Lancet Oncology, Bd. 22, Nr. 2: S. 223-234
Witzens-Harig, Mathias; Viardot, Andreas; Keller, Ulrich; Wosniok, Julia; Deuster, Oliver; Klemmer, Jennifer; Geueke, Anne-Marie; Meissner, Julia; Ho, Anthony D.; Atta, Johannes; Marks, Reinhard; La Rosee, Paul; Buske, Christian; Dreyling, Martin H. und Hess, Georg
(2021):
The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL - Results From the Phase-II STORM Trial.
In: Hemasphere, Bd. 5, Nr. 10, e636
Schmitz, Norbert; Truemper, Lorenz; Bouabdallah, Krimo; Ziepert, Marita; Leclerc, Mathieu; Cartron, Guillaume; Jaccard, Arnaud; Reimer, Peter; Wagner, Eva; Wilhelm, Martin; Sanhes, Laurence; Lamy, Thierry; de Leval, Laurence; Rosenwald, Andreas; Roussel, Muriel; Kroschinsky, Frank; Lindemann, Walter; Dreger, Peter; Viardot, Andreas; Milpied, Noeel; Gisselbrecht, Christian; Wulf, Gerald; Gyan, Emmanuel; Gaulard, Philippe; Bay, Jacques Olivier; Glass, Bertram; Poeschel, Viola; Damaj, Gandhi; Sibon, David; Delmer, Alain; Bilger, Karin; Banos, Anne; Haenel, Mathias; Dreyling, Martin; Metzner, Bernd; Keller, Ulrich; Braulke, Friederike; Friedrichs, Birte; Nickelsen, Maike; Altmann, Bettina und Tournilhac, Olivier
(2021):
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
In: Blood, Bd. 137, Nr. 19: S. 2646-2656
Kayser, Sabine; Schlenk, Richard F.; Lebon, Delphine; Carre, Martin; Goetze, Katharina S.; Stoelzel, Friedrich; Berceanu, Ana; Schaefer-Eckart, Kerstin; Peterlin, Pierre; Hicheri, Yosr; Rahme, Ramy; Raffoux, Emmanuel; Chermat, Fatiha; Krause, Stefan W.; Aulitzky, Walter E.; Rigaudeau, Sophie; Noppeney, Richard; Berthon, Celine; Goerner, Martin; Jost, Edgar; Carassou, Philippe; Keller, Ulrich; Orvain, Corentin; Braun, Thorsten; Saillard, Colombe; Arar, Ali; Kunzmann, Volker; Wemeau, Mathieu; de Wit, Maike; Niemann, Dirk; Bonmati, Caroline; Schwaenen, Carsten; Abraham, Julie; Aljijakli, Ahmad; Haiat, Stephanie; Kraemer, Alwin; Reichle, Albrecht; Gnadler, Martina; Willekens, Christophe; Spiekermann, Karsten; Hiddemann, Wolfgang; Mueller-Tidow, Carsten; Thiede, Christian; Roellig, Christoph; Serve, Hubert; Bornhaeuser, Martin; Baldus, Claudia D.; Lengfelder, Eva; Fenaux, Pierre; Platzbecker, Uwe und Ades, Lionel
(2021):
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative.
In: Haematologica, Bd. 106, Nr. 12: S. 3100-3106
Heider, M.; Eichner, Ruth; Stroh, Jacob; Morath, Volker; Kuisl, Anna; Zecha, Jana; Lawatscheck, Jannis; Baek, Kheewoong; Garz, Anne-Kathrin; Rudelius, Martina; Deuschle, Friedrich-Christian; Keller, Ulrich; Lemeer, Simone; Verbeek, Mareike; Gotze, Katharina S.; Skerra, Arne; Weber, Wolfgang A.; Buchner, Johannes; Schulman, Brenda A.; Kuster, Bernhard; Fernandez-Saiz, Vanesa und Bassermann, Florian
(2021):
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma.
In: Molecular Cell, Bd. 81, Nr. 6
Hess, Georg; Wagner, Karola; Keller, Ulrich; La Rosee, Paul; Atta, Johannes; Hübel, Kai; Lerchenmueller, Christian; Schoendube, Daniel; Witzens-Harig, Mathias; Ruckes, Christian; Medler, Christoph; Oordt, Christina van; Klapper, Wolfram; Theobald, Matthias und Dreyling, Martin
(2020):
Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma.
In: Hemasphere, Bd. 4, Nr. 3, e398
Broeckelmann, Paul J.; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V.; Sasse, Stephanie; Soekler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Huettmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Mettler, Jasmin; Fuchs, Michael; Tresckow, Bastian von; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter und Engert, Andreas
(2020):
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.
In: Jama Oncology, Bd. 6, Nr. 6: S. 872-880
O'Connor, Tracy; Zhou, Xiaolan; Kosla, Jan; Adili, Arlind; Beccaria, Maria Garcia; Kotsiliti, Elena; Pfister, Dominik; Johlke, Anna-Lena; Sinha, Ankit; Sankowski, Roman; Schick, Markus; Lewis, Richard; Dokalis, Nikolaos; Seubert, Bastian; Hoechst, Bastian; Inverso, Donato; Heide, Danijela; Zhang, Wenlong; Weihrich, Petra; Manske, Katrin; Wohlleber, Dirk; Anton, Martina; Hoellein, Alexander; Seleznik, Gitta; Bremer, Juliane; Bleul, Sabine; Augustin, Helmut G.; Scherer, Florian; Ködel, Uwe; Weber, Achim; Protzer, Ulrike; Foerster, Reinhold; Wirth, Thomas; Aguzzi, Adriano; Meissner, Felix; Prinz, Marco; Baumann, Bernd; Hoepken, Uta E.; Knolle, Percy A.; Baumgarten, Louisa von; Keller, Ulrich und Heikenwalder, Mathias
(2019):
Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention.
In: Cancer Cell, Bd. 36, Nr. 3
Jurinovic, Vindi; Metzner, Bernd; Pfreundschuh, Michael; Schmitz, Norbert; Wandt, Hannes; Keller, Ulrich; Dreger, Peter; Dreyling, Martin; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva und Weigert, Oliver
(2018):
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
In: Biology of Blood and Marrow Transplantation
Borchmann, Peter; Haverkamp, Heinz; Lohri, Andreas; Mey, Ulrich; Kreissl, Stefanie; Greil, Richard; Markova, Jana; Feuring-Buske, Michaela; Meissner, Julia; Duehrsen, Ulrich; Ostermann, Helmut; Keller, Ulrich; Maschmeyer, Georg; Kuhnert, Georg; Dietlein, Markus; Kobe, Carsten; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Diehl, Volker und Engert, Andreas
(2017):
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP(escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
In: Lancet Oncology, Bd. 18, Nr. 4: S. 454-463
Pfreundschuh, Michael; Murawski, Niels; Zeynalova, Samira; Ziepert, Marita; Löffler, M.; Hänel, Matthias; Dierlamm, Judith; Keller, Ulrich; Dreyling, Martin; Truemper, Lorenz; Frickhofen, Norbert; Hünerlitürkoglu, Ali-Nuri; Schmitz, Norbert; Pöschel, Viola; Rixecker, Tanja; Berdel, Christian; Rübe, Christian; Held, Gerhard und Zwick, Carsten
(2017):
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.
In: British Journal of Haematology, Bd. 179, Nr. 3: S. 410-420
Herhaus, Peter; Habringer, Stefan; Philipp-Abbrederis, Kathrin; Vag, Tibor; Gerngross, Carlos; Schottelius, Margret; Slotta-Huspenina, Julia; Steiger, Katja; Altmann, Torben; Weisser, Tanja; Steidle, Sabine; Schick, Markus; Jacobs, Laura; Slawska, Jolanta; Müller-Thomas, Catharina; Verbeek, Mareike; Subklewe, Marion; Peschel, Christian; Wester, Hans-Jürgen; Schwaiger, Markus; Götze, Katharina und Keller, Ulrich
(2016):
Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia.
In: Haematologica, Bd. 101, Nr. 8: S. 932-940
[PDF, 2MB]
Eichner, Ruth; Heider, Michael; Fernández-Sáiz, Vanesa; Bebber, Frauke van; Garz, Anne-Kathrin; Lemeer, Simone; Rudelius, Martina; Targosz, Bianca-Sabrina; Jacobs, Laura; Knorn, Anna-Maria; Slawska, Jolanta; Platzbecker, Uwe; Germing, Ulrich; Langer, Christian; Knop, Stefan; Einsele, Herrmann; Peschel, Christian; Haass, Christian 
ORCID: https://orcid.org/0000-0002-4869-1627; Keller, Ulrich; Schmid, Bettina; Götze, Katharina S.; Kuster, Bernhard und Bassermann, Florian
(2016):
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.
In: Nature Medicine, Bd. 22, Nr. 7: S. 735-743
ORCID: https://orcid.org/0000-0002-4869-1627; Keller, Ulrich; Schmid, Bettina; Götze, Katharina S.; Kuster, Bernhard und Bassermann, Florian
(2016):
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.
In: Nature Medicine, Bd. 22, Nr. 7: S. 735-743
Illerhaus, Gerald; Kasenda, Benjamin; Ihorst, Gabriele; Egerer, Gerlinde; Lamprecht, Monika; Keller, Ulrich; Wolf, Hans-Heinrich; Hirt, Carsten; Stilgenbauer, Stephan; Binder, Mascha; Hau, Peter; Edinger, Matthias; Frickhofen, Norbert; Bentz, Martin; Möhle, Robert; Röth, Alexander; Pfreundschuh, Michael; Baumgarten, Louisa von; Deckert, Martina; Hader, Claudia; Fricker, Heidi; Valk, Elke; Schorb, Elisabeth; Fritsch, Kristina und Finke, Jürgen
(2016):
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.
In: Lancet Haematology, Bd. 3, Nr. 8, E388-E397